至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Phospholipid-coated guanosine diphosphate auxiliary CaP active nanoparticles can systematically improve the efficiency of gene therapy for cancer disease

ACS Biomater. Sci. Eng. 2020; 
Nan Jia, Xirui Zhang, Wenpan Li, Dawei Chen, and Haiyang Hu
Products/Services Used Details Operation
Catalog Peptides Nuclear localization sequence (NLS) peptide of the SV40 T antigen (CGGGPKKKRKVED; MW, 1401.7) was provided by GenScript Corporation (Shanghai, China). Get A Quote

摘要

Endogenous active substance guanosine diphosphate (GDP) is involved in the physiological process of DNA transfection and expression in the cytoplasm by binding to Ran proteins. To substantially improve the gene delivery efficiency of nanoparticles, phospholipidcoated Ca(P-GDP)/pDNA/NLS hybrid nanoparticles were prepared using GDP as a common biophosphorus source based on the biological process of exogenous gene expression in the cells. This nanoparticle has a relative uniform particle size distribution and in vitro stability. The addition of GDP in nanoparticles significantly enhanced the gene expression efficiency with good biocompatibility. Moreover, an in vivo study further verified that hybrid nanoparticles... More

关键词

bioactive nanoparticles, guanosine diphosphate (GDP), nuclear location signal (NLS), gene therapy